A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ICM / ischemic cardiomyopathy

[Related PubMed/MEDLINE]
Total Number of Papers: 351
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ICM  (>> Co-occurring Abbreviation)
Long Form:   ischemic cardiomyopathy
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trial. ICDs, NICM, WARCEF
2019 Combined Endocardial-Epicardial Versus Endocardial Catheter Ablation Alone forVentricular Tachycardia in StructuralHeart Disease: A Systematic Review and Meta-Analysis. ARVC, CI, endo, endo-epi, NICM, RR, RR, RR, VT
2019 Comparison between Glyceryl Trinitrate and Trimetazidine in Ischaemic Cardiomyopathy Patients. BSMMU, GTN, TMZ
2019 Comparison of In-Hospital Outcomes of Patients With-Versus-Without Ischemic Cardiomyopathy Undergoing Left Ventricular Assist Device Placement. CI, HF, LVAD, OR
2019 Contemporary characteristics and outcomes of adults with familial dilated cardiomyopathy listed for heart transplantation. CI, FDCM, HR, HT, LVAD, NICM
2019 Feasibility of entirely subcutaneous ICD™ systems in patients with coronary artery disease. CAD, LVEF, SCD
2019 Genome-wide DNA methylation encodes cardiac transcriptional reprogramming in human ischemic heart failure. ---
2019 Molecular Alterations of Nucleocytoplasmic Transport in Patients on the Heart Transplantation Waiting List and Its Correlation With the Severity and Etiology of Heart Failure. ATPCa, DCM, ECMO, EXP4, HF, HT, IMP5, Nup153, Nup160, RanGAP1
2019 Rivaroxaban Suppresses the Progression of Ischemic Cardiomyopathy in a Murine Model of Diet-Induced Myocardial Infarction. MI, PAR
10  2019 Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis. AF, HF, HR, NICM, PS
11  2018 A cohort study of cardiac resynchronization therapy in patients with chronic Chagas cardiomyopathy. CCC, CRT, NYHA
12  2018 ASB1 differential methylation in ischaemic cardiomyopathy: relationship with left ventricular performance in end-stage heart failure patients. CNT, LV
13  2018 Association between myocardial extracellular volume and strain analysis through cardiovascular magnetic resonance with histological myocardial fibrosis in patients awaiting heart transplantation. CMR, CVF, DCM, ECV, MOLLI
14  2018 Beta-1-Adrenergic Receptor Antibodies in Acute Coronary Syndrome: Is Less Sometimes More? ACS, AP, NSTEMI, PET/CT, STEMI
15  2018 Bioinformatics analysis of common differential genes of coronary artery disease and ischemic cardiomyopathy. CAD, DAVID, GEO, GO, KEGG, PPI
16  2018 Bundle branch reentrant ventricular tachycardia: review and case presentation. BBRVT, ICD, NICM, WCT
17  2018 Can enhanced external counter pulsation as a non-invasive modality be useful in patients with ischemic cardiomyopathy after coronary artery bypass grafting? ACC, CABG, EECP
18  2018 CarDiac MagnEtic Resonance for Primary Prevention Implantable CardioVerter DebrillAtor ThErapy international registry: Design and rationale of the DERIVATE study. CMR, ICD, LVEF, MACE, NICM, SCD, TTE, VT
19  2018 Cardiac resynchronization therapy: A comparative analysis of mortality in African Americans and Caucasians. ACEI, ARB, CI, CRT, GFR
20  2018 Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy. NICM, VT
21  2018 Cell Spray Transplantation of Adipose-derived Mesenchymal Stem Cell Recovers Ischemic Cardiomyopathy in a Porcine Model. ADSC
22  2018 Circulating miR-192 is a prognostic marker in patients with ischemic cardiomyopathy. miR
23  2018 Comparison of Mesenchymal Stem Cell Efficacy in Ischemic Versus Nonischemic Dilated Cardiomyopathy. DCM
24  2018 Comparison of ventricular tachyarrhythmia recurrence between ischemic cardiomyopathy and dilated cardiomyopathy: a retrospective study. DCM, ICD, LVEDV, LVEF, VF, VT
25  2018 Electrical latency predicts the optimal left ventricular endocardial pacing site: results from a multicentre international registry. AHR, BIVENDO, LV, LVENDO
26  2018 Electrophysiologic features of protected channels in late postinfarction patients with and without spontaneous ventricular tachycardia. CV, VT
27  2018 Epicardial ventricular tachycardia in ischemic cardiomyopathy: Prevalence, electrophysiological characteristics, and long-term ablation outcomes. ENDO, EPI, VT
28  2018 Etiologic impact on difference on clinical outcomes of patients with heart failure after cardiac resynchronization therapy: A systematic review and meta-analysis. CRT, LVEDD, LVEF, LVESV, NICM, PASP
29  2018 High-resolution three-dimensional late gadolinium-enhanced cardiac magnetic resonance imaging to identify the underlying substrate of ventricular arrhythmia. ARVC, CMR, HCM, HR-LGE, LGE, NICM, NSVT, SHD, VA, VF/SCD, VT
30  2018 Identification of a Common Different Gene Expression Signature in Ischemic Cardiomyopathy. DEGs, GO, RT-PCR
31  2018 Impact of chronic total occlusion on ventricular arrhythmia and mortality in ischaemic cardiomyopathy patient with implantable cardiac defibrillator: a meta-analysis. ICD, VA
32  2018 Impact of Late Gadolinium Enhancement on mortality, sudden death and major adverse cardiovascular events in ischemic and nonischemic cardiomyopathy: A systematic review and meta-analysis. LGE, LVEF, NICM
33  2018 Impact of Number of Oral Antiarrhythmic Drug Failures Before Referral on Outcomes Following Catheter AblationofVentricular Tachycardia. AAD, SHD, VT
34  2018 Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death. CI, DAI-PP, ICD, NICM, SCD
35  2018 Implantable cardioverter-defibrillator therapy in hypertrophic cardiomyopathy: A SIMPLE substudy. CI, DCM, DT, HCM, HR, ICD, SIMPLE
36  2018 Improvement of increased cQTd is associated with heart function in patients with ischemic heart failure. CHF, DCM, ECG, LVEF, NYHA
37  2018 Increased Serum Interleukin-34 Levels Are Related to the Presence and Severity of Cardiac Dysfunction in Patients With Ischemic Cardiomyopathy. CAD, CI, CKD, CSF-1R, HF, IL-34, NYHA, OR
38  2018 Jeopardized Myocardium Defined by Late Gadolinium Enhancement Magnetic Resonance Imaging Predicts Survival in Patients With Ischemic Cardiomyopathy: Impact of Revascularization. JM
39  2018 Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy. CRT-D, CRT-P, HF, HR, MACE, NICM
40  2018 Myocardial viability-State of the art: Is it still relevant and how to best assess it with imaging? CAD, CMR, DSE, LV
41  2018 Outcome of catheter ablation for ventricular tachycardia in patients with ischemic cardiomyopathy: A systematic review and meta-analysis of randomized clinical trials. ACM, CA, CVD, OR, RR, VT
42  2018 Outcomes in Patients With Hypertrophic Cardiomyopathy Awaiting Heart Transplantation. HCM, HT
43  2018 Overexpression of collagen type III in injured myocardium prevents cardiac systolic dysfunction by changing the balance of collagen distribution. LV, N-OPN, SV
44  2018 Percutaneous Revascularization for Ischemic Ventricular Dysfunction: Rationale and Design of the REVIVED-BCIS2 Trial: Percutaneous Coronary Intervention for IschemicCardiomyopathy. HF, LVEF, OMT, PCI
45  2018 Prediction of the ischemic origin of functional mitral regurgitation in patients with systolic heart failure through posterior mitral leaflet angle. CD, CI, DCM, FMR, MV, OR, Sm, TA, TDI
46  2018 Qualitative and Quantitative Analysis of Cardiac Progenitor Cells in Cases of Myocarditis and Cardiomyopathy. CPC, DCM
47  2018 Quantitative deformation analysis differentiates ischaemic and non-ischaemic cardiomyopathy: sub-group analysis of the VINDICATE trial. CMR, HF, LV, LVEF, NICM
48  2018 Relationship of myocardial hibernation, scar, and angiographic collateral flow in ischemic cardiomyopathy with coronary chronic total occlusion. CMR, CTO, FDG, LGE
49  2018 Respiratory Sinus Arrhythmia Quantified with Linear and Non-Linear Techniques to Classify Dilated and Ischemic Cardiomyopathy. CHF, DCM, DM, RSA
50  2018 Role of Myocardial Perfusion Study in Differentiating Ischemic versus Nonischemic Cardiomyopathy Using Quantitative Parameters. CAG, EDV, EF, ESV, MPI, NICM, NPV, PPV, SDS, SRS
51  2018 Scar burden, not intraventricular conduction delay pattern, is associated with outcomes in ischemic cardiomyopathy patients receiving cardiac resynchronization therapy. CRT, IVCD, LBBB, LVEF
52  2018 Sympathetic denervation in patients with ischemic cardiomyopathy and risk on ventricular tachy-arrhythmias. A pilot study. ICD, LVEF
53  2018 The Relationship between Serum Zinc Level and Heart Failure: A Meta-Analysis. HF, IDCM
54  2018 Therapeutic efficacy and safety of Shexiang Baoxin Pill combined with trimetazidine in elderly patients with heart failure secondary to ischaemic cardiomyopathy: A systematic review and meta-analysis. 6MWD, HF, LVEDD, LVEF, LVESD, RCTs, SBP
55  2018 Transcriptome Profiling Reveals PHLDA1 as a Novel Molecular Marker for Ischemic Cardiomyopathy. ---
56  2018 Transplantation of Endothelial Progenitor Cells Overexpressing miR-126-3p Improves Heart Function in Ischemic Cardiomyopathy. EPCs, MO-EPCs, NM-EPCs
57  2017 A real world wearable cardioverter defibrillator experience - Very high appropriate shock rate in ischemic cardiomyopathy patients at a European single-center. SCD, VA, WCD
58  2017 Aberrant Epicardial Adipose Tissue Extracellular Matrix Remodeling in Patients with Severe Ischemic Cardiomyopathy: Insight from Comparative Quantitative Proteomics. CAD, EAT, ECM, GO, PSR
59  2017 Adding Defibrillation Therapy to CardiacResynchronization on the Basisofthe MyocardialSubstrate. CI, CRT, DCM
60  2017 Alteration of Cholinergic Anti-Inflammatory Pathway in Rat With Ischemic Cardiomyopathy-Modified Electrophysiological Function of Heart. ---
61  2017 Anti-cardiac troponin antibodies in clinical human disease: a systematic review. DCM, EDMD, PPCM
62  2017 Association of mean platelet volume with presence of non-viable myocardium in ischaemic cardiomyopathy. CI, CRP, MPV, NLR, OR, PET, PLR, ROC
63  2017 Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods. 2-3SD, ICD, LGE, NICM
64  2017 Catheter ablation in the treatment of electrical storm: Integrative review. ES, ICDs
65  2017 Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy. CRT, D-HCM, HF, HR, IDCM, LVESV
66  2017 Does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure? LGE-CMR, LVSD, NICM
67  2017 Echocardiography and Electrocardiography Variables Correlate With the New York Heart Association classification: An Observational Study of Ischemic Cardiomyopathy Patients. CI, CO, NYHA, OR, T2DM, UCG
68  2017 Effects of Transendocardial Stem Cell Injection on Ventricular Proarrhythmia in Patients with Ischemic Cardiomyopathy: Results from the POSEIDON and TAC-HFT Trials. BMC, HRV, MSC, VE
69  2017 Electroanatomic Properties of the Myocardium Predict Response to CD34+ Cell Therapy in Patients With Ischemic and Nonischemic Heart Failure. DCM, LVEF
70  2017 Enhanced Therapeutic Effects of Human iPS Cell Derived-Cardiomyocyte by Combined Cell-Sheets with Omental Flap Technique in Porcine Ischemic Cardiomyopathy Model. EF, hiPS-CMs, SPIO
71  2017 Gene expression profiling reveals genes and transcription factors associated with dilated and ischemic cardiomyopathies. DCM, DEGs, PPIs, TFs
72  2017 High-frequency power within the QRS complex in ischemic cardiomyopathy patients with ventricular arrhythmias: Insights from a clinical study and computer simulation of cardiac fibrous tissue. DFP, ITFP, L-VA, QRS
73  2017 Identification of biomarkers for ischemic cardiomyopathy based on microarray data analysis. CAMs, GO, KEGG, PPI
74  2017 Kcnj11 Ablation Is Associated With Increased Nitro-Oxidative Stress During Ischemia-Reperfusion Injury: Implications for Human Ischemic Cardiomyopathy. ---
75  2017 Long-Term Outcomes of Catheter Ablationof Electrical Storm in Nonischemic DilatedCardiomyopathy Compared WithIschemicCardiomyopathy. CA, NIDCM, VT
76  2017 MAGNETIC VT study: a prospective, multicenter, post-market randomized controlled trial comparing VT ablation outcomes using remote magnetic navigation-guided substrate mapping and ablation versus manual approach in a low LVEF population. ICD, LVEF, RMN, VT
77  2017 Minute Myocardial Injury as Measured by High-Sensitive Troponin T Serum Levels Predicts the Response to Intracoronary Infusion of Bone Marrow-Derived Mononuclear Cells in Patients With Stable Chronic Post-Infarction Heart Failure: Insights From the TOPCARE-CHD Registry. BMCs, hs-TnT
78  2017 Myocardial wall thinning predicts transmural substrate in patients with scar-related ventricular tachycardia. DCM, LAVA, MDCT, PMC, SWT, VT, WT
79  2017 Optimal cut-off value of reverse remodeling to predict long-term outcome after cardiac resynchronization therapy in patients with ischemic cardiomyopathy. BNP, CRT, LBBB, LV, LVESV, NICM
80  2017 Prediction and prognosis of ventricular tachycardia recurrence after catheter ablation with remote magnetic navigation for electrical storm in patients with ischemic cardiomyopathy. CI, HR, RMN, VT
81  2017 Predictors of mortality and ICD shock therapy in primary prophylactic ICD patients-A systematic review and meta-analysis. LVEF
82  2017 Safety and efficacy of epicardial approach to catheter ablation of ventricular tachycardia - An institutional experience. GM, NICM
83  2017 Severe ischemic cardiomyopathy with mechanical complications: Still a surgical disease. ESVI, LV, RV
84  2017 Sexual dimorphisms of mRNA and miRNA in human/murine heart disease. DCM, GOs, HCM, LV
85  2017 Study on the expression and mechanism of plasma microRNA-21 in patients with ischemic cardiomyopathy. LVEDV, LVEF, qRT-PCR, TC, TG
86  2017 Temporary biventricular support with extracorporeal membrane oxygenation: a feasible therapeutic approach for cardiogenic shock with multiple organ failure. FM, LVAD, NICM, p-ECMO, PPCM, VAD
87  2017 Thyroid hormone biosynthesis machinery is altered in the ischemic myocardium: An epigenomic study. LV, TH, TPO
88  2017 Who still remains at risk of arrhythmic death at time of implantable cardioverter-defibrillator generator replacement? GR, ICD, LVEF, NICM
89  2017 [ECG score to predict ICD therapies in patients with nonischemic cardiomyopathy and primary prophylactic CRT-D]. CRT-D, CRT-P, LVEF, MSES, NICM, ROC
90  2017 [Surgical Regeneration Therapy Using Myoblast Sheets for Severe Heart Failure]. HGF, VEGF
91  2016 Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy. aHR, CRT, HF, ICD, NICM
92  2016 Advances in the Treatment of Ischemic Diseases by Mesenchymal Stem Cells. MSCs
93  2016 Association between Latest Activated Sites in the Left Ventricle and Akinetic Segments in Patients with Ischemic Cardiomyopathy. LV, TDI
94  2016 Changes in Implantation Patterns and Therapy Rates of Implantable Cardioverter Defibrillators over Time in Ischemic and Dilated Cardiomyopathy Patients. AS, IAS, ICD
95  2016 Characteristics and Outcomes of Patients With Myocarditis Listed for Heart Transplantation. NICM
96  2016 Correlating blood levels of 8-hydroxydeoxyguanosine to hOGG1 genotypes and the incidence of ischemic cardiomyopathy. ---
97  2016 Differences in predictors of implantable cardioverter-defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies. AF, CI, CRT, ICDs, OR
98  2016 Does Survival on the Heart Transplant Waiting List Depend on the Underlying Heart Disease? CHD, CI, HCM, OHT, RCM
99  2016 Effectiveness of cardiac resynchronization therapy by the frequency of revascularization procedures in ischemic cardiomyopathy patients. CRT-D, HF, ICD, MADIT-CRT, VF, VT
100  2016 Electrophysiologic Scar Substrate in Relation to VT: Noninvasive High-Resolution Mapping and Risk Assessment with ECGI. DS, ECGI, EGM, EP, LPs, TS, VT